Lynparza : Orphan designation withdrawal assessment report (post-authorisation)
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Source
European Medicines Agency
Additional Information
medication.label.product_type
orphan-maintenance-report-post
medication.label.permit_number
EMA/214775/2018
medication.label.permit_validity
First published: 2018-05-28T02:00:00Z
Documents
Related Medications
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
AI Voice
Listen to the article content live